A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.
The suzetrigine, which only acts on pain neurons, is the first innovation in analgesia in the last 20 years. "It stands out ...
About 80 million Americans fill prescriptions each year for medications to treat new instances of moderate to severe pain, ...
The U.S. Food and Drug Administration has approved a novel prescription pain medication that targets sodium channels involved ...
they can cause problems with addiction.” “These pain medications, suzetrigine, Journavx as it’s called, works sort of more at the location of the pain, sort of trying to block the signals ...
Experts said millions of people across the country are prescribed a medicine for moderate to severe acute pain each year, so Journavx can help establish a new level of care. The FDA reports this ...
Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...
About half those prescriptions are written for opioid medications, which can lead to dependence and addiction. A new type of pain medication to hit the market will create an alternative — it’s ...
A new opioid-free pain medication was approved by the U.S. Food ... "Suzetrigine’s non-opioid mechanism eliminates risks of misuse, addiction and respiratory depression, making it a safer ...